A series of new 1,2-diphenylimidazole derivatives (1a-x) were synthesized and evaluated for their ability to potentiate γ-aminobutyric acid (GABA)-evoked currents in Xenopus laevis oocytes expressing recombinant human GABAA receptors. Many of these compounds enhanced GABA action with potencies (EC50 ) 0.19-19 μM) and efficacies (maximal efficacies of up to 640%) similar to or greater than those of anesthetics such as etomidate, propofol, and alphaxalone. Structure-activity relationship analysis revealed that the presence of an ester moiety in the imidazole ring was required for full agonist properties, while modifications made in the phenyl rings affected potency and efficacy, with ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H- 4-imidazolecarboxylate showing the highest potency. These compounds potentiated the [3H]- GABA binding to rat brain membranes, suggesting a site of interaction different from that of GABA. As for etomidate, mutation of asparagine-265 in the 2 subunit of the GABAA receptor into serine reduced the ability of derivative 1i to modulate the GABA function.

Synthesis, Structure-Activity Relationships at the GABAA Receptor in Rat Brain, and Differential Electrophysiological Profile at the Recombinant Human GABAA Receptor of a Series of Substituted 1,2-Diphenylimidazoles / Asproni, Battistina; Talani, G; Busonero, F; Pau, A; Sanna, S; Cerri, R; Mascia, M. P.; Sanna, E; Biggio, G.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 48:(2005), pp. 2638-2645. [10.1021/jm049120y]

Synthesis, Structure-Activity Relationships at the GABAA Receptor in Rat Brain, and Differential Electrophysiological Profile at the Recombinant Human GABAA Receptor of a Series of Substituted 1,2-Diphenylimidazoles

ASPRONI, Battistina;
2005-01-01

Abstract

A series of new 1,2-diphenylimidazole derivatives (1a-x) were synthesized and evaluated for their ability to potentiate γ-aminobutyric acid (GABA)-evoked currents in Xenopus laevis oocytes expressing recombinant human GABAA receptors. Many of these compounds enhanced GABA action with potencies (EC50 ) 0.19-19 μM) and efficacies (maximal efficacies of up to 640%) similar to or greater than those of anesthetics such as etomidate, propofol, and alphaxalone. Structure-activity relationship analysis revealed that the presence of an ester moiety in the imidazole ring was required for full agonist properties, while modifications made in the phenyl rings affected potency and efficacy, with ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H- 4-imidazolecarboxylate showing the highest potency. These compounds potentiated the [3H]- GABA binding to rat brain membranes, suggesting a site of interaction different from that of GABA. As for etomidate, mutation of asparagine-265 in the 2 subunit of the GABAA receptor into serine reduced the ability of derivative 1i to modulate the GABA function.
2005
Synthesis, Structure-Activity Relationships at the GABAA Receptor in Rat Brain, and Differential Electrophysiological Profile at the Recombinant Human GABAA Receptor of a Series of Substituted 1,2-Diphenylimidazoles / Asproni, Battistina; Talani, G; Busonero, F; Pau, A; Sanna, S; Cerri, R; Mascia, M. P.; Sanna, E; Biggio, G.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 48:(2005), pp. 2638-2645. [10.1021/jm049120y]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/44561
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 22
social impact